Dr. Tristan McClure-Begley joined the Defense Advanced Research Project Agency (DARPA) as a Program Manager in October 2017. His scientific pursuits at the agency involve novel chemical biology approaches to treating disease and injury, and developing methods to accelerate and protect learning and executive functions.
Dr. McClure-Begley came to DARPA from the University of Colorado, Boulder, where he was a Research Assistant Professor in the Department of Molecular, Cellular, and Developmental Biology. His academic studies focused on molecular mechanisms of perturbations to complex biological systems, particularly drugs of abuse, toxins, and neurodevelopmental disorders. Prior to his faculty appointment at Colorado, Dr. McClure-Begley was a postdoctoral fellow in the Department of Psychiatry at the Yale University School of Medicine, and an alumnus of the Yale/NIDA Neuroproteomics Center.
He received his Doctor of Philosophy in Integrative Physiology and a Graduate Certificate in Behavioral Genetics from the University of Colorado, Boulder.
Podcasts / Webinars
Join HDIAC Thursday, October 29, from 1200 to 1300 EDT for our next webinar presentation titled “Biostasis.” Please register in advance for the webinar at: https://www.anymeeting.com/PIID=EF55DC85814E39
This webinar provides an overview of the Defense Advanced Research Project Agency’s (DARPA) Biostasis program. The Biostasis program aims to extend the time for lifesaving medical treatment, often referred to as “the Golden Hour,” following traumatic injury or acute infection, thus increasing survivability for military personnel operating in far-forward conditions with limited access to medical professionals or trauma centers. To do so, Biostasis is developing novel chemical biology approaches that reversibly and controllably slow biological systems without cold-chain to stabilize and protect their functional capacity until medical intervention is possible.